Alcon to acquire WaveTec Vision

Article

Alcon has entered into an agreement to acquire WaveTec Vision, developer of the ORA System, the first commercialized intraoperative guidance system for cataract surgeons implanting intraocular lenses (IOLs).

Fort Worth, TX-Alcon has entered into an agreement to acquire WaveTec Vision, developer of the ORA System, the first commercialized intraoperative guidance system for cataract surgeons implanting intraocular lenses (IOLs).

Alcon introduces Air Optix Colors

The ORA System allows surgeons to see incisions and IOL alignment in real time to support optimal positioning of IOLs during cataract surgery. The ORA System performs additional measurements to confirm the surgeon’s lens selection and placement within the eye.

Alcon plans to integrate the ORA System into its existing cataract refractive suite which includes: Verion, the LenSx femtosecond laser, the Centurion phacoemulsification system, and the LuxOR LX3 microscope.

The ORA System obtains intra-operative wavefront data during cataract surgery to calculate IOL power, as well as magnitude and axis of astigmatism. The marriage of the ORA System and Alcon’s Verion imaged-guided system is intended to increase the surgeon’s clinical confidence when using IOLs. According to Alcon, the combined technologies are designed to improve patient outcomes and enhance the overall post-surgical patient experience with IOLs.

Upon closing, Alcon will acquire full rights to the ORA System technology and immediately begin the integration of the company into its surgical business franchise. The transaction is subject to closing conditions, including anti-trust approval.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Rachelle Lin, OD, MS, FAAO
Paul Karpecki, OD, FAAO
Melissa Barnett, OD, FAAO, FSLS, FBCLA, gave 2 presentations alongside other ODs and MDs at CRU 2025.
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.